
VA Won't Research Medical Marijuana for Chronic Pain or PTSD Among Veterans
An inquiry by 10 Democrats on the House Committee on Veterans’ Affairs into whether or not the Department of Veterans Affairs (VA) would research medical marijuana in veterans suffering from posttraumatic stress disorder (PTSD) and chronic pain was met with denial.
An inquiry by 10 Democrats on the House Committee on Veterans’ Affairs into whether or not the Department of Veterans Affairs (VA) would research medical marijuana in veterans suffering from posttraumatic stress disorder (PTSD) and chronic pain was met with denial.
In a letter to Representative Tim Walz, D-Minnesota, ranking member of the Committee on Veterans’ Affairs, VA Secretary David Shulkin, MD,
Walz and his fellow Democrats had
Shulkin noted in his response that there is “a rapidly increasing body of evidence” that supports other treatments for chronic pain, such as exercise, yoga, mindfulness, acupuncture, and cognitive behavioral therapy.
“I have heard the stories of veterans who have used cannabis medicinally to help them cope with physical and psychological injuries of war," Walz
Chronic pain is pervasive among veterans. In 2015, the VA reported that about 60% of veterans returning from combat deployment suffer from chronic pain. Only 30% of Americans nationwide experience chronic pain. A
On January 16, Walz and his fellow Democrats wrote another letter to Shulkin as a follow up to his response.
“While we share your dedication to improving the care of veterans with chronic pain and PTSD, we are concerned VA has not explored all treatment options,” they wrote. “We urge you to join us and the 90% of veterans who are in favor of VA research into medical cannabis.”
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.